Cargando…

Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints

SIMPLE SUMMARY: A vital task in contemporary cancer research is to discover clinically useful molecular markers for diagnosis and prognosis from microarray or sequencing data. However, reliable and efficient statistical tools are lacking in terms of marker screening and selection for high-throughput...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Chenlu, Bandyopadhyay, Dipankar, Sarkar, Devanand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856670/ https://www.ncbi.nlm.nih.gov/pubmed/36672328 http://dx.doi.org/10.3390/cancers15020379

Ejemplares similares

Gene Screening in High-Throughput Right-Censored Lung Cancer Data
por: Ke, Chenlu, et al.
Publicado: (2022)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis
por: Pane, Katia, et al.
Publicado: (2020)

Prognosis Analysis and Perioperative Research of Elderly Patients with Non-Muscle-Invasive Bladder Cancer under Computed Tomography Image of Three-Dimensional Reconstruction Algorithm
por: Ke, Hongying, et al.
Publicado: (2022)

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma
por: Feng, Yueyi, et al.
Publicado: (2019)

Smoking Behaviors and Prognosis in Patients With Non–Muscle-Invasive Bladder Cancer in the Be-Well Study
por: Kwan, Marilyn L., et al.
Publicado: (2022)

Surrogate endpoints and competing risk of death in cardiac arrest research
por: McCredie, Victoria A., et al.
Publicado: (2016)

Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
por: Michaelson, M D, et al.
Publicado: (2004)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Controlling Nutritional Status Score Evaluates Prognosis in Patients With Non-Muscle Invasive Bladder Cancer
por: Huang, Jiaguo, et al.
Publicado: (2021)

Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy
por: Wang, Zhifeng, et al.
Publicado: (2022)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Proteomics research on muscle-invasive bladder transitional cell carcinoma
por: Niu, Hai Tao, et al.
Publicado: (2011)

Analysis and design of randomised clinical trials involving competing risks endpoints
por: Tai, Bee-Choo, et al.
Publicado: (2011)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder Cancer
por: Chen, Zhongqing, et al.
Publicado: (2012)

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer
por: Shim, Ui Jae, et al.
Publicado: (2013)

Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer
por: Li, Jingxian, et al.
Publicado: (2021)

Assessment of Immunological Features in Muscle-Invasive Bladder Cancer Prognosis Using Ensemble Learning
por: Gavriel, Christos G., et al.
Publicado: (2021)

Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
por: Zhang, Qi, et al.
Publicado: (2022)

Identification and validation of immunohistochemical marker panels to predict the prognosis of muscle invasive bladder cancer
por: Ying, Yidie, et al.
Publicado: (2023)

Detection of novel biomarkers for early detection of Non-Muscle-Invasive Bladder Cancer using Competing Endogenous RNA network analysis
por: Kouhsar, Morteza, et al.
Publicado: (2019)

Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression
por: Jung, Minsun, et al.
Publicado: (2020)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

AB175. Girdin protein is a novel prognosis predictor for patients with non-muscle invasive bladder cancer
por: Wu, Zhouliang, et al.
Publicado: (2016)

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score
por: Breyer, Johannes
Publicado: (2017)

Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
por: Huang, Wei-Lun, et al.
Publicado: (2020)

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
por: Tae, Bum Sik, et al.
Publicado: (2017)

Non-muscle invasive bladder cancer risk stratification
por: Isharwal, Sumit, et al.
Publicado: (2015)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Molecular Landscape of Non-Muscle Invasive Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

Active surveillance for non-muscle invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

Bladder preservation versus radical cystectomy in transitional cell carcinoma and squamous cell carcinoma muscle invasive bladder cancer
por: Mohamed, Dalia O., et al.
Publicado: (2021)

Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma
por: Manna, Debashri, et al.
Publicado: (2020)

Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma
por: Tadin, Tomislav, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3q3a4f8ce2h613silmfbtms5p7